Dr. Israel Guerrero Mantilla, M.D.
What this data tells you about Dr. Guerrero Mantilla
Dr. Israel Guerrero Mantilla is a cardiovascular disease in Fort Myers, FL, with 15 years in practice. Based on federal Medicare data, Dr. Guerrero Mantilla performed 4,621 Medicare services across 3,548 unique beneficiaries.
Between the years covered by Open Payments, Dr. Guerrero Mantilla received a total of $3,084 from 21 pharmaceutical and/or device companies across 73 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Guerrero Mantilla is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 1,035 | $93 | $184 |
| Electrocardiogram (EKG), 12-lead | 459 | $10 | $63 |
| Regadenoson injection (Lexiscan) for heart stress test | 456 | $44 | $114 |
| Echocardiogram, transthoracic | 258 | $146 | $538 |
| Anticoagulant management of patient taking warfarin | 200 | $8 | $26 |
| Hospital follow-up visit, moderate complexity | 191 | $66 | $125 |
| Prothrombin time test (blood clotting) | 186 | $4 | $17 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 178 | $319 | $900 |
| Hospital follow-up visit, high complexity | 154 | $99 | $177 |
| Initial hospital admission, high complexity | 133 | $145 | $350 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 124 | $55 | $298 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 115 | $11 | $105 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 100 | $9 | $25 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan | 89 | $2,206 | $4,700 |
| Nuclear medicine study of heart muscle blood flow by pet | 89 | $150 | $377 |
| Programming of dual lead pacemaker system | 85 | $54 | $152 |
| Cardiac catheterization | 65 | $215 | $864 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 62 | $88 | $253 |
| New patient office visit (45-59 min) | 54 | $111 | $306 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 41 | $14 | $66 |
| Office visit, established patient, complex (40-54 min) | 41 | $119 | $270 |
| Coronary stent placement | 40 | $485 | $1,500 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 37 | $2 | $10 |
| Ultrasound of both sides of head and neck blood flow | 37 | $151 | $482 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 34 | $324 | $686 |
| Programming of dual lead implantable defibrillator system | 30 | $61 | $198 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 26 | $63 | $234 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 25 | $647 | $950 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 25 | $9 | $32 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 24 | $21 | $62 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 22 | $19 | $51 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 21 | $6 | $22 |
| External shock to heart to regulate heart beat | 20 | $86 | $271 |
| Electrocardiogram (ecg) 2-day continuous | 17 | $14 | $74 |
| Programming of single lead pacemaker system | 16 | $49 | $130 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $86 | $263 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $14 | $51 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $17 | $71 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $11 | $71 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 13 | $127 | $686 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 13 | $233 | $940 |
| Ultrasound of heart, follow-up | 12 | $66 | $247 |
| Ultrasound study of arm and leg arteries | 12 | $68 | $200 |
| Programming of multiple lead implantable defibrillator system | 11 | $67 | $234 |
| Evaluation of cardiac rhythm monitor system | 11 | $33 | $97 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Guerrero Mantilla is a clinical cardiology specialist, with above-average Medicare volume (top 23% in FL), and low-engagement industry engagement, with 15 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Guerrero Mantilla experienced with office visit, established patient (30-39 min)?
Does Dr. Guerrero Mantilla receive payments from pharmaceutical companies?
How do Dr. Guerrero Mantilla's costs compare to other cardiovascular diseases in Fort Myers?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology